Pliant Therapeutics reels in $100m Series C

South San Francisco-based Pliant Therapeutics Inx, a clinical stage biopharmaceutical company focused on treating fibrosis, has raised $100 million in Series C financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this